52%
Average Reduction in PTSD Symptoms
Participants experienced an average 52% reduction in PTSD symptom severity in the FDA-cleared clinical trial.
68%
No Longer Met the Clinical Threshold for PTSD
More than two-thirds of the participants no longer met the clinical criteria for PTSD following MeRT treatment.
